Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Floseal to Prevent Lymphocele After Renal Transplantation
ChiCTR-IIR-16009066Phase 4Recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jan 1990
- Modality
- Recombinant Proteins and Enzymes, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of gelatin + thrombin in lymphocele and end-stage kidney disease (ESKD) (2 arms), sponsored by The Chinese University of Hong Kong. Primary endpoint: Incidence of symptomatic lymphocele. Started Jan 1990; status: recruiting.
02
Drugs
gelatin + thrombin
03
Conditions
lymphoceleend-stage kidney disease (ESKD)
Beyond the preview
Go deeper on ChiCTR-IIR-16009066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-16009066.